METX — ME Therapeutics Holdings Balance Sheet
0.000.00%
- CA$111.26m
- CA$109.63m
- 34
- 20
- 13
- 10
Annual balance sheet for ME Therapeutics Holdings, fiscal year end - August 31st, CAD millions except per share, conversion factor applied.
2020 August 31st | 2021 August 31st | 2022 August 31st | 2023 August 31st | 2024 August 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.05 | 0.073 | 0.077 | 0.647 | 1.5 |
| Net Total Receivables | 0.02 | 0.002 | 0.023 | 0.007 | 0.017 |
| Prepaid Expenses | |||||
| Total Current Assets | 0.07 | 0.075 | 0.102 | 0.672 | 1.54 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0 | 0 | 0 | 0 | 0 |
| Net Intangible Assets | |||||
| Total Assets | 0.07 | 0.075 | 0.102 | 0.672 | 1.54 |
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.006 | 0.033 | 0.174 | 0.148 | 0.063 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.046 | 0.093 | 0.234 | 0.148 | 0.063 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 0.024 | -0.018 | -0.131 | 0.523 | 1.48 |
| Total Liabilities & Shareholders' Equity | 0.07 | 0.075 | 0.102 | 0.672 | 1.54 |
| Total Common Shares Outstanding |